Media & Resources

Press Releases

IAVI Receives GSK Funding for the Human Vaccines Project to Accelerate Development of Vaccines for Infectious Diseases and Cancer

February 13, 2015

NEW YORK – The International AIDS Vaccine Initiative (IAVI) has received a grant of US$350,000 from GSK to support implementation of the Human Vaccines Project, a new public-private partnership seeking to transform global disease prevention by collaboratively addressing some of the key scientific challenges in vaccine development across diseases. The GSK grant will help to establish…

Scientific Publications

Creating an African HIV clinical research and prevention trials network HIV prevalence incidence and transmission

Scientific Publications

Two classes of broadly neutralizing antibodies within a single lineage directed to the high mannose patch of HIV envelope

Press Releases

GSK Global Vaccines Chairman Moncef Slaoui Joins IAVI Board of Directors

January 8, 2015

The International AIDS Vaccine Initiative (IAVI) is pleased to announce that Dr. Moncef Slaoui, Chairman, Vaccines, GSK, has joined its Board of Directors. “Moncef Slaoui brings a wealth of experience in translating promising research into practical vaccines for use throughout the world,” said IAVI President and CEO Margie McGlynn. “His counsel will be crucial to…

Scientific Publications

Well ordered trimeric HIV 1 subtype B and C soluble spike mimetics generated by negative selection display native like properties

Scientific Publications

Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV 1 recipients

Scientific Publications

The Potential Impact of Preventive HIV Vaccines in China Results and Benefits of a Multi Province Modeling Collaboration

Scientific Publications

Broad and persistent Gag specific CD8 T cell responses are associated with viral control but rarely drive viral escape during primary HIV 1 infection

1…125 126127128 129…218 of 218

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI Receives GSK Funding for the Human Vaccines Project to Accelerate Development of Vaccines for Infectious Diseases and Cancer

Creating an African HIV clinical research and prevention trials network HIV prevalence incidence and transmission

Two classes of broadly neutralizing antibodies within a single lineage directed to the high mannose patch of HIV envelope

GSK Global Vaccines Chairman Moncef Slaoui Joins IAVI Board of Directors

Well ordered trimeric HIV 1 subtype B and C soluble spike mimetics generated by negative selection display native like properties

Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV 1 recipients

The Potential Impact of Preventive HIV Vaccines in China Results and Benefits of a Multi Province Modeling Collaboration

Broad and persistent Gag specific CD8 T cell responses are associated with viral control but rarely drive viral escape during primary HIV 1 infection

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI Receives GSK Funding for the Human Vaccines Project to Accelerate Development of Vaccines for Infectious Diseases and Cancer

Creating an African HIV clinical research and prevention trials network HIV prevalence incidence and transmission

Two classes of broadly neutralizing antibodies within a single lineage directed to the high mannose patch of HIV envelope

GSK Global Vaccines Chairman Moncef Slaoui Joins IAVI Board of Directors

Well ordered trimeric HIV 1 subtype B and C soluble spike mimetics generated by negative selection display native like properties

Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV 1 recipients

The Potential Impact of Preventive HIV Vaccines in China Results and Benefits of a Multi Province Modeling Collaboration

Broad and persistent Gag specific CD8 T cell responses are associated with viral control but rarely drive viral escape during primary HIV 1 infection

Subscription Type